BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 1999
View Archived Issues
Sugen awarded U.S. patent for transcript imaging technology
Read More
Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho
Read More
Potent thrombin inhibitors with heterocyclic structure synthesized at Lilly
Read More
ACAT-inhibitory urea derivatives claimed by Mitsubishi for lipid disorders
Read More
S-19777: novel ET antagonist of microbial origin
Read More
Carbapenems in development at Sankyo
Read More
Xanthine oxidase inhibitors for hyperuricemia, gout described by Yoshitomi in patent literature
Read More
U.S. patent issued to Millennium covers novel forms of caspase 8
Read More
Anika outlines plans for 1999 as regards product pipeline
Read More
Proleukin receives orphan drug status for two new indications
Read More
New antiobesity target a focus of attention at recent Japanese meeting
Read More
New family of gene-regulating enzymes discovered by Signal, Hebrew University
Read More
FDA approves OTC status for Elan's nicotine patch
Read More
Combinations of K-12 and other anti-HIV compounds tested in vitro for synergy
Read More
Phase II trial results published for repaglinide for treatment of type II diabetes
Read More
PSC-833 modulates the tumor disposition of vinca alkaloids in vitro and in vivo
Read More
More anti-HIV, antimalarial agents available for licensing from NIH
Read More
Nonpsychoactive, neuroprotective cannabinoids available for licensing from NIH
Read More
CNI-1493 attenuates hemodynamic and cytokine responses to LPS in rats
Read More
Favorable preclinical, clinical results continue to encourage development of ABT-378
Read More
AxyS initiates phase I clinical trial of APC-2059 for treatment of psoriasis
Read More
Fujisawa obtains Japanese marketing rights to Zeneca's atypical antipsychotic quetiapine
Read More
Prodrug glucocorticoid NM-135 displays potent antiinflammatory activity, good side effect profile
Read More
Ilex and Symphar begin phase I studies of SR-45023A
Read More
Interneuron receives milestone payment from Lilly under Prozac agreement
Read More
Bristol-Myers Squibb seeks approval for new antibiotic for respiratory and other infections
Read More
Remacemide provides neuroprotection during CPB
Read More
Photofrin approved in U.K. for palliative treatment of esophageal cancer and late-stage lung cancer
Read More
